This inventor holds 1 USPTO granted patent. Top assignee: Uniwersytet Jagielloński. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Kamil Przyborowski: Innovator in Aromatic Sulphonamides
Introduction
Kamil Przyborowski is a notable inventor based in Cracow, Poland. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on aromatic sulphonamides. His research focuses on developing compounds that can modulate the activity of protein disulfide isomerase (PDI), which has implications in various therapeutic areas.
Latest Patents
Kamil Przyborowski holds a patent for "Aromatic sulphonamides derivatives that inhibit PDI A3, their synthesis and use." This invention relates to a new group of aromatic sulphonamides derivatives that are designed to inhibit PDI A3. The small molecule inhibitors he has developed display promising antiplatelet, antithrombotic, and anticancer activities. This patent represents a significant advancement in the search for effective therapeutic agents.
Career Highlights
Kamil is affiliated with the Jagiellonian University, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential applications in treating various diseases, showcasing his commitment to advancing medical science.
Collaborations
Kamil has collaborated with talented individuals such as Marta Stojak and Diana Zelencova. These partnerships have enriched his research endeavors and fostered a collaborative environment that encourages innovation.
Conclusion
Kamil Przyborowski is a distinguished inventor whose work on aromatic sulphonamides has the potential to impact the medical field significantly. His dedication to research and innovation continues to pave the way for new therapeutic solutions.